US Stock MarketDetailed Quotes
VIR Vir Biotechnology
- 7.120
- +0.170+2.45%
Close Nov 22 16:00 ET
- 7.120
- 0.0000.00%
Post 20:01 ET
980.57MMarket Cap-1811P/E (TTM)
7.270High6.880Low891.75KVolume7.000Open6.950Pre Close6.36MTurnover0.96%Turnover RatioLossP/E (Static)137.72MShares13.09052wk High0.79P/B658.71MFloat Cap6.56052wk Low--Dividend TTM92.52MShs Float141.010Historical High--Div YieldTTM5.61%Amplitude6.560Historical Low7.135Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Vir Biotechnology Stock Forum
Vir Biotechnology Presents Positive Chronic Hepatitis Delta Clinical Trial Data and Announces Initiation of Phase 3 Registrational Program
Phase 3 Eclipse Program to Evaluate Tobevibart and Elebsiran
Vir Biotechnology Receives Positive Opinion on Orphan Drug Designation for Tobevibart and Elebsiran in Chronic Hepatitis Delta From European Medicines Agency
Firstly of first you need to pump to 20
Vir Biotechnology Announces Closing of Exclusive Worldwide License Agreement With Sanofi for Multiple Potential Best-in-Class Clinical-Stage T-Cell Engagers
your own platform is most valuable and made 2 Billion for the company. You just let people go…
No comment yet